New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives
about
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseClinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of lifeProfile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPDSystematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsUmeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage.Optimum treatment for chronic obstructive pulmonary disease exacerbation prevention.Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.Drugs for chronic obstructive pulmonary diseaseRecent updates in chronic obstructive pulmonary disease.When is dual bronchodilation indicated in COPD?Tiotropium/Olodaterol: A Review in COPD.Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies.Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management.Phenotyping Before Starting Treatment in COPD?Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Small Airway Disease in Patients with Chronic Obstructive Pulmonary DiseaseEligibility of real-life patients with COPD for inclusion in RCTs: a commentary.Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease.Pharmacological treatment for COPD; GOLD 2017 changes direction.Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.
P2860
Q26770504-2980DDFC-251D-4852-8EE1-ADCB2FD0D637Q26801134-054A01AE-049B-4EDE-A91C-886DE178458EQ26825822-383A21BA-C397-4F24-B604-B355AD1A674FQ30245662-CEE3CF57-82FD-4FE2-AD20-EF9DC4DD1903Q35749377-2A0FD2F0-337E-43CB-B3C1-E26CDC15AC0BQ37055678-49A75449-DBAE-4E46-BFD6-172415654053Q37287627-AAB9DCE1-0B68-4C17-BCD5-AD52073ACAE8Q37583834-C1785081-8144-4272-AF48-699C853B46ACQ37603590-D2BC4543-04F1-4F9D-BE75-DF51DCD25B10Q37647174-0D6AD3B6-BF71-4728-B35C-FA858A3F478DQ38631285-5FE04F23-2F87-4299-9B75-A2A93E276CD7Q38641441-4A77158A-2123-4D1F-B3D7-89ACD0342013Q38673383-0C1D363B-B747-4EBD-8C3C-8B2AD998BB12Q38721028-0DC425D2-7B5F-49AA-959D-876DB367B5A2Q39040871-256CF1C2-8C96-40B4-BBE6-0F1CF5CE8A45Q39226768-20EA858D-9EC2-474E-9CD5-05A5307AA182Q39420903-096D2576-58F0-4DB9-BA7B-30B128D299C2Q40598255-BBCB96FD-ADA7-41AF-B7B7-B4C98B2C2D28Q41658426-5D61832A-B873-4F0B-A86B-9FE3034B645AQ42333511-292C07D1-06F4-4B9C-90BB-9C8A09593115Q42701518-20212159-CB40-42E6-85E8-D78785F3C7D1Q42920605-176F335E-55B6-49E2-9D60-604D664E1640Q47122143-0EEBC2A0-28AC-4D85-8C09-AEF5AE1D571DQ47657304-3E277621-11FC-4AC2-994E-335346BA3C09Q54336237-51AA972D-B97B-4969-86A0-F313129D21B4Q55451529-08408E74-433A-4271-9684-C34765B2F18B
P2860
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
New combination bronchodilator ...... idence and future perspectives
@ast
New combination bronchodilator ...... idence and future perspectives
@en
New combination bronchodilator ...... idence and future perspectives
@nl
type
label
New combination bronchodilator ...... idence and future perspectives
@ast
New combination bronchodilator ...... idence and future perspectives
@en
New combination bronchodilator ...... idence and future perspectives
@nl
prefLabel
New combination bronchodilator ...... idence and future perspectives
@ast
New combination bronchodilator ...... idence and future perspectives
@en
New combination bronchodilator ...... idence and future perspectives
@nl
P2860
P3181
P356
P1476
New combination bronchodilator ...... idence and future perspectives
@en
P2093
Dave Singh
P2860
P304
P3181
P356
10.1111/BCP.12545
P407
P577
2015-05-01T00:00:00Z